J

Ongoing Research on Tumor-Agnostic Drugs in Solid Tumors: Combination Approach for Precision Oncology

By Jacob Adashek 2 Videos
70 views
March 28, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
25:35
Total Health

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Feat. S. Kazmi
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
20:52
Total Health

Diagnostics in Lung Cancer: A Comprehensive Discussion - Best of Lun…

Feat. T. Boyle
06:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of C…

Feat. A. Medford
41:07
Yale Cancer Center

Understanding Your Cancer Risk and Options for Cancer Prevention

Feat. V. Giri, T. Shroff
23:00
Total Health

ctDNA and MRD: Who, What, and Then What?

Feat. A. Parikh
11:43
University of Colorado Department of Medicine

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

Feat. L. Kondapalli
29:43
Michigan Medicine

GI and Hepatic Complications of Cancer Immunotherapy

Feat. R. Fontana
19:05
International Congress on Cancer Metastasis

Could We Cure Metastatic Breast Cancer?

Feat. L. Pusztai
21:23
2023 Evolution Conference

Comprehensive Genomic Profiling: Why Aren't We Doing It?

Feat. J. Meisel
18:46
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024

Biomarkers in Immuno-Oncology: Road to Personalized Immunotherapy

Feat. C. Jackson
20:31
Total Health

Diagnostics: Genomics for Treatment Planning of Breast Cancer

Feat. R. L. Mahtani
09:48
ecancer

ESMO 2022 on the PATHFINDER Study: A New Era of Early Cancer Detecti…

Feat. D. Schrag
04:18
Insights from 2023 SABCS

SABCS 2023 Insights: "Comparison of NGS Results From the Cerebr…

Feat. L. Huppert
14:27
ecancer

Latest in Lung Cancer Genomic Testing

Feat. S. Popat
13:50
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

Molecular Therapies in Pancreatic Ductal Adenocarcinoma: NGS for All

Feat. P. Philip
11:26
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Bispecific

Feat. J. Gulley
20:06
ImmunoTherapy Bridge 2023

Bispecific vs. Combination Therapy - PRO Combination Therapy

Feat. A. Patnaik
08:04
ASCO 2022 Conference Coverage

ASCO 2022 on OPTIMA Preliminary Trial: Disparity Between Ki67 Measur…

Feat. R. Stein